Products

Five - fold Ceramide Biomimetic Liposome

    • Product Name: Five - fold Ceramide Biomimetic Liposome
    • Alias: five_fold_ceramide_biomimetic_liposome
    • Einecs: 921-504-4
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    573684

    Product Name Five-fold Ceramide Biomimetic Liposome
    Type Skincare ingredient
    Main Function Restores and strengthens skin barrier
    Ceramide Content Contains five types of ceramides (NP, AP, EOP, NS, AS)
    Delivery System Biomimetic liposomes
    Suitable For All skin types, especially sensitive and dry skin
    Texture Lightweight and easily absorbed
    Hydration Provides long-lasting moisture
    Repair Action Aids in repairing damaged skin
    Anti Irritation Helps reduce skin sensitivity and irritation
    Usage Can be added to creams, serums, and lotions
    Additional Benefit Enhances skin smoothness and softness

    As an accredited Five - fold Ceramide Biomimetic Liposome factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging features a sleek white 30ml bottle with blue-accented labeling, highlighting "Five-fold Ceramide Biomimetic Liposome" in bold lettering.
    Shipping The Five-fold Ceramide Biomimetic Liposome is securely packaged in chemical-resistant containers to ensure product stability during transit. Shipped under controlled temperature conditions, it is delivered promptly via trusted carriers, adhering to safety and regulatory guidelines. Detailed documentation accompanies each shipment for safe handling and compliance with international shipping standards.
    Storage Five-fold Ceramide Biomimetic Liposome should be stored in a tightly sealed container at 2-8°C, protected from light and moisture. Avoid repeated freeze-thaw cycles. Handle under aseptic conditions to maintain product integrity. Keep away from strong acids, alkalis, and oxidizing agents. Properly label and monitor storage conditions to ensure chemical stability and optimal performance.
    Application of Five - fold Ceramide Biomimetic Liposome

    Applications of Five-Fold Ceramide Biomimetic Liposome in Industrial Manufacturing

    Our Five-Fold Ceramide Biomimetic Liposome, produced in dedicated GMP facility lines, supports advanced formulation strategies for skin barrier reinforcement and delivery systems across personal care, pharmaceutical, and hygiene sectors. Below are key downstream industrial applications, each shaped by specific regulatory environments, technical demands, and product requirements.

    1. Advanced Facial Moisturizer Formulation

    Leading skincare manufacturers integrate five-fold ceramide biomimetic liposomes into emulsion-based facial moisturizers for premium hydration and barrier repair. Our material, structurally similar to natural human ceramides, blends efficiently during the oil phase dispersion stage. Consistent lamellar alignment within the emulsion is monitored using polarizing microscopy and controlled shear mixing, ensuring reproducible active delivery. These processes target finished creams with clinically validated skin barrier restoration capabilities, demanded by cosmeceutical marketers focused on sensitive and mature skin populations.

    Industry compliance standards

    • EU Regulation (EC) No 1223/2009 on Cosmetic Products
    • United States FDA 21 CFR 701 & 740
    • China GB/T 29665-2013 for Cosmetic Safety
    • ISO 22716:2007 Cosmetic GMP Guidelines

    Typical usage ratio

    • 0.5–2.0% by weight of final formulation
    • Concentration adjusted based on emulsion viscosity, target skin type, and label claims verification

    Downstream process integration

    • Added post-emulsification under moderate cooling (35–40°C)
    • Gentle stir-in to avoid vesicle rupture and ensure homogeneous distribution
    • Inline UV-VIS monitoring for content uniformity

    Final product types

    • Hydrating day creams
    • Barrier-repair night creams
    • Dermatologist-recommended clinical moisturizers
    • Medical-grade prescription barrier ointments

    2. Sensitive-Scalp Personal Wash Products

    Scalp treatment manufacturers deploy five-fold ceramide biomimetic liposomes in rinse-off and leave-on formulations to reduce trans-epidermal water loss and support scalp barrier regeneration. Our liposome structure accommodates frequent surfactant exposure, stabilizing active ceramides during the hot-add phase. This approach allows mass production of gentler hair care solutions suited for scalp-prone dermatitis and post-procedural care kits, gaining popularity among professional salon and trichology brands.

    Industry compliance standards

    • EU Regulation (EC) No 1223/2009
    • Japan Ministry of Health, Labour and Welfare MHLW ordinance for quasi-drugs
    • ISO 16128:2016 Natural and Organic Cosmetic Technical Criteria
    • Cruelty-Free and Vegan Society label criteria (if relevant to customer claims)

    Typical usage ratio

    • 0.3–1.2% active by weight
    • Adjusted according to surfactant system, rinse-off contact time, and scalp skin tolerability goals

    Downstream process integration

    • Loaded post-neutralization during the cooling phase of batch
    • Low-speed tank circulation for 10–15 min to achieve lamellar layer alignment
    • QC support by FTIR spectral confirmation of intact structure

    Final product types

    • Mild scalp shampoos for sensitive skin
    • No-rinse scalp repair lotions
    • Post-dye treatment scalp balms
    • Pediatric scalp wash concentrates

    3. Wound Care and Barrier Medical Dressings

    Medical device and advanced wound care manufacturers utilize five-fold ceramide biomimetic liposomes to enhance synthetic skin dressings, hydrocolloids, and bioactive barrier pads. Integration occurs during aqueous gel blending, where preserving vesicle integrity is critical for controlled ceramide release upon skin contact. This approach supports rapid re-epithelization, moisture retention, and prevention of secondary infection in chronic wound applications. Regulatory documentation includes biocompatibility, cytotoxicity, and residual solvent analysis to support international medical device certifications.

    Industry compliance standards

    • ISO 10993-1:2018 Biocompatibility for Medical Devices
    • US FDA 21 CFR 820 QSR for Medical Devices
    • EU MDR (Regulation (EU) 2017/745)
    • Japan PMDA Medical Device GCP

    Typical usage ratio

    • 1.0–5.0% by wet mass in hydrogel or hydrocolloid matrix
    • Ratio increases for high-exudate wounds or prolonged contact dressings

    Downstream process integration

    • Dispersed with cross-linked polymer gel precursors prior to setting
    • Low shear mixing under aseptic protocols; in-line batch record tracking
    • Validated by release profile and cell migration assays

    Final product types

    • Sterile hydrogel wound pads
    • Adhesive barrier dressings for chronic ulcers
    • Transdermal healing patches
    • Pediatric burn and abrasion protectives

    4. Pharmaceutical Skin Delivery Vehicles

    The pharmaceutical sector leverages five-fold ceramide biomimetic liposomes as targeted carriers for APIs in topical delivery systems. Formulators incorporate the ingredient in pre-emulsified bases for corticosteroid, antifungal, or moisturizing prescription drugs. Controlled mixing conditions at chilled temperatures help retain liposome encapsulation efficiency, supporting claims of enhanced dermal penetration and reduced irritation. Quality assurance documentation includes CMC dossiers, process validation, and stability assessments to meet stringent global drug submission requirements.

    Industry compliance standards

    • Good Manufacturing Practice (GMP, ICH Q7)
    • US FDA 21 CFR 210/211 for Drug Product Manufacture
    • European Pharmacopoeia (Ph. Eur.) Monographs on Lipid-based Excipients
    • China Pharmacopoeia (ChP) Topical Preparation Monographs

    Typical usage ratio

    • 0.7–3.0% by weight depending on co-solvent system and API loading
    • Adjusted to balance permeability, API stability, and skin tolerability

    Downstream process integration

    • Blended after main API dissolution, typically post-micronization
    • Inline temperature-controlled dosing (20–25°C) in closed reactors
    • Final phase filtration (0.45 μm) to ensure microbiological safety

    Final product types

    • Prescription dermatological creams (e.g., for atopic dermatitis)
    • Topical corticosteroid-liposome emulsions
    • Liposome-enhanced antifungal ointments
    • Transdermal gel drugs for chronic skin conditions

    5. Hygiene and Adult Care Barrier Products

    Hygiene manufacturers employ five-fold ceramide biomimetic liposomes in adult care barrier creams, incontinence care lotions, and cleansing foams to minimize moisture-associated skin damage. The raw material withstands repeated exposure to urine and sanitizing agents while maintaining occlusive and protective benefits. Production focuses on stable emulsification and ease of application, with rigorous stability, patch, and zone-of-inhibition testing required for hospital and institutional product approvals.

    Industry compliance standards

    • US FDA OTC Skin Protectant Monograph 21 CFR 347
    • EN ISO 13485:2016 for Medical Hygiene Products
    • ASTM D6610-20 Standard for Absorbent Hygiene Barrier Creams
    • Health Canada Natural and Non-prescription Health Products Directorate (NNHPD) guidelines

    Typical usage ratio

    • 0.6–2.5% by total formulation mass
    • Higher ranges for overnight-contact creams or after-care balms

    Downstream process integration

    • Mixed during secondary emulsion phase following preservative addition
    • Monitored by HPLC for ceramide active content stability across batches
    • Batch validated by absorbency and occlusion trials

    Final product types

    • Adult and pediatric diaper barrier creams
    • Moisture-protective cleansing foams
    • Institutional skincare balms for bedridden patients
    • Medical personal hygiene amphoteric lotions

    6. High-Performance Decorative Cosmetics

    Color cosmetic manufacturers use five-fold ceramide biomimetic liposomes in foundation, BB creams, and CC creams targeting all-in-one complexion enhancement and prolonged skin barrier support. Integration focuses on maintaining color pigment dispersion stability, ensuring the uninterrupted encapsulation of actives during heat-injection and cooling stages. QC teams run particle size and lamellar integrity assessments post blending to verify layer consistency, which is vital for stable, long-wear cosmetics highly demanded in premium markets.

    Industry compliance standards

    • EU Regulation (EC) No 1223/2009 for Color Cosmetic Safety
    • US FDA Color Additive and Cosmetic Ingredient Restrictions
    • Japan MHLW Colorant Approval List (JSCI)
    • ISO/TR 17276:2014 for Nanomaterials in Cosmetics

    Typical usage ratio

    • 0.1–0.8% by weight, adjusted for vehicle (water-in-oil vs. oil-in-water) and pigment content
    • Lower dose for sheer-tint products, higher for full-coverage base makeup

    Downstream process integration

    • Dispersed during pigment wetting or stabilization stage
    • Gentle mixing under nitrogen blanket for oxidation-sensitive actives
    • Batch-to-batch tracking by color consistency and liposomal encapsulation efficiency

    Final product types

    • Long-wear liquid foundations
    • Color-correction BB and CC creams
    • Hydrating makeup primers
    • Skin-repairing tinted sunscreens

    Free Quote

    Competitive Five - fold Ceramide Biomimetic Liposome prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Five-fold Ceramide Biomimetic Liposome: Our Answer to Skin Barrier Care

    Building from Real-World Experience in Ceramide Synthesis

    Years of hands-on work with advanced lipid chemistry led us to develop the Five-fold Ceramide Biomimetic Liposome. As a manufacturer, we learned that replicating the intricate balance of skin’s natural protective lipids isn’t simple. Ceramides play a crucial role in maintaining the skin barrier, and many products out there either offer low purity or combine only a single ceramide type. Our process tackles this by creating a product that includes five distinct ceramide molecules, all encapsulated in stable, skin-mimetic liposomes.

    Product Model and Perspective on Specifications

    During formulation, we prioritized real compatibility with the skin's natural stratum corneum. We aimed for a blend containing Ceramide NP, Ceramide AP, Ceramide EOP, Ceramide NS, and Ceramide AS. Each of these lipids takes part in restoring the balance and resilience that modern skin care demands. By synthesizing and integrating all five ceramides into biomimetic vesicles, we found markedly better performance, especially for formulations targeting weakened or sensitive skin. The liposome model we chose avoids single-source lipid issues common in standard formulations and ensures higher bioavailability where it matters most: on the living skin barrier.

    How Liposome Encapsulation Alters Formulation Performance

    Over time, we saw more customers struggling with unstable or low-absorption ceramide powders and emulsions—whether those ceramides broke down under heat or simply did not make it to their target layers in the skin. Adapting phospholipid vesicle technology, we encapsulated our blend of five ceramides for greater stability and controlled release. This move also helped our partners simplify their stabilizer systems, as we buffered the ceramides from much of the typical oxidative or hydrolytic damage.

    Through batch testing, we compared emulsion droplet size, release kinetics, and shelf-life between the Five-fold Ceramide Biomimetic Liposome and other forms on the market, such as simple ceramide powders or non-encapsulated blends. Liposome encapsulation consistently improved not only dissolution and spreadability but also retention of ceramide function through prolonged storage. Clinical partners saw observable improvement in TEWL and visual redness after switching formulas. Those results didn’t come from chance—they stemmed from painstaking development and real-world iterative testing.

    Differences in Real Use: Beyond Labels and Ingredient Lists

    It’s easy to claim a product “contains ceramides,” but manufacturing challenges often cut corners in practice. Some suppliers use only one type, relying heavily on Ceramide NP, sometimes in synthetic forms that mismatch the human barrier. In our experience, this monotypic approach cannot rebuild depleted skin as well as a balanced blend. We see this when evaluating finished formulations’ effect on skin microbiome and barrier properties with customers—it’s rarely enough to just add a single component to an otherwise conventional base.

    Adding to this, particle size and vesicle stability make or break the actual delivery. Many ceramide ingredients form aggregates or separate when mixed with active botanicals or antioxidants, especially when heated during processing. Our solution, honed over more than a decade, controls particle size down to submicron range, ensuring tight lamellar layers that mirror healthy skin on a microscopic scale. The take-away after years of technical audits: not all ceramide blends deliver functional skin repair, even if the label claims so. It’s the delivery system, molecular diversity, and formulation science that draw the real line between success and mediocrity.

    Case Examples: Where the Five-fold System Wins

    A cosmetics client approached us after several unsuccessful attempts to stabilize their “barrier cream.” Their previous supplier sold them raw ceramide EOP as a powder. This ingredient demonstrated poor dispersibility and lacked the natural synergy found in healthy skin. Our team ran a formulation trial using our Five-fold Ceramide Biomimetic Liposome—this time, the finished cream passed accelerated stability testing with flying colors. No separation, no active degradation, and consumer testers reported a noticeable improvement in both hydration and comfort.

    With another customer, a brand focusing on milder formulas for reactive skin, raw ceramide blends caused irritation—even at low dosages. The culprit wasn’t simply the source of the ceramides but the lack of true mimicry of skin’s own ratio and structure. By reformulating with our liposomal product, their new lotion scored much higher on patch testing—lower irritation, higher user compliance. Consistent performance like this only happens when the manufacturing process respects both the science of skin lipids and the art of stable formulation.

    Specifications That Matter to Us—Learning from Feedback

    Over countless batches, we listened to feedback from chemists, dermatologists, and end-users. They told us that what truly matters is not just claims on molecular weight or purity but how well the ceramides remain functional at the point of use. For this reason, we fix the ratio of our five ceramides to closely match natural skin, and we guarantee liposomal vesicle size within a precise range—usually below 200 nanometers. Our production team regularly reviews spectrometry and microscopic analysis to verify lipid incorporation and batch consistency.

    Water dispersibility also became a focus after early partners had trouble blending lesser ceramides into aqueous bases or emulsions. After optimizing phospholipid ratios and refining process controls, the Five-fold Ceramide Biomimetic Liposome now disperses quickly in both cold and warm phases, even in tricky surfactant systems. This innovation grew out of many rounds of scaling up and troubleshooting where “off-the-shelf” ingredients couldn’t keep up with actual manufacturing needs.

    Usage Insights: Going Beyond “Add to Formula”

    As a chemical manufacturer, we notice a big gap in how most people use ceramide products. Many formulators simply add ceramides at the final cooling phase, expecting miracles. Our technical support teaches formulators to treat these liposomes differently: gentle mixing, protection from extreme pH, and the right order of emulsification preserve the functional vesicles that actually repair skin. Our support team shares protocols refined after watching formulas fail or succeed in the real world, not just on paper. Simple tweaks to the process, like staged mixing and temperature controls, enabled customers to produce creams and serums that delivered the full promise of multi-ceramide technology.

    Another common challenge surfaced among manufacturers creating high-viscosity or surfactant-heavy systems. Older generation ceramide powders performed poorly when blended with thickening agents or anionic surfactants. In contrast, our liposomal format handles these challenges by suspending ceramide molecules in a structure that endures shear stress and prevents precipitation. Years of side-by-side trials on actual equipment gave us this edge—it wasn’t just luck or clever marketing.

    Why We Chose Biomimicry and Five Ceramide Types

    Skin’s outer layer consists of a finely balanced mix of ceramide types, cholesterol, and fatty acids structured in repeating lamellae. Through microscopy and lipidomics studies, we learned that missing even one type of ceramide tips the balance, weakening the barrier and leaving it vulnerable. Products with only Ceramide NP or AP often show some benefit, but they fall short of supporting true barrier restoration. That’s what drove us to synthesize and encapsulate all five major subtypes, in the same ratio found in healthy human skin. Decades in the lab taught us that technological shortcuts show up quickly as product failures or disappointing clinical outcomes.

    Since adopting this biomimetic approach, we noticed consistently positive feedback from both professional formulators and dermatologists. Many cite better user tolerance, less redness, and more rapid skin recovery compared to earlier “single ceramide” products. This comes not from one fancy marketing claim, but from following the science of how skin heals.

    Comparing to Other Forms: Direct Observations and Lab Data

    Looking at the ingredient market, traditional ceramide powders require heavy solubilizers or solvents and bring heat sensitivity to formulation plants. Emulsifiers and surfactants often denature single-ceramide structures during processing, particularly when ramping up batch sizes. Some suppliers promote pre-emulsified ceramide dispersions but neglect to match the ceramide profile to that found in human stratum corneum. The result, in our hands-on testing, means less durable barrier support and frequent instability—engineered forms separate or degrade under mild stress conditions.

    Using our Five-fold Ceramide Biomimetic Liposome, we reduced the need for complicated co-solvents and preservatives. In lab stability tests, our encapsulation method protected lipid integrity for over a year at elevated temperatures. This was a step change for customers who previously struggled through short shelf-life or unpredictable texture. Further, the surface activity of our vesicle system permits easier blending with actives like niacinamide, Vitamin C derivatives, or peptides, as the liposomes stabilize mixed-phase systems without extra synthetic stabilizers. Our technical collaboration with skin research labs confirms that finished products keep their ceramide content and structure well beyond what’s expected with standard powder or oil-dispersed types.

    Real Life Performance: Stories from our Production Lines

    Each batch tells a story. In the past, we fielded calls about “white flecks” in test skin creams or “layering out” of supposed ceramide complexes. These headaches usually pointed back to low dispersibility and simple single-ceramide matrices. Through decades of troubleshooting, we introduced process modifications such as temperature ramping and staged ingredient addition—a necessity to keep complex lipid blends stable through scale-up. Manufacturing the biomimetic liposome, we validate both vesicle structure and active distribution using chromatography and imaging, so our customers don’t have to troubleshoot the chemistry after delivery.

    Formulators send us samples for performance validation. The feedback we value most shows up in end-user results: creams using our Five-fold Ceramide Biomimetic Liposome earn higher marks for skin feel and reparative effect. With clinical partners, topical application consistently improves skin hydration within as little as one week, demonstrating that the blend “does the work” over time, not just during first use. We see reduced irritation in patch testing studies, even on sensitive or compromised skins.

    Productivity Gains: Efficiency Lessons from Actual Production

    A problem many manufacturers face is the drag of added complexity when formulating functional skincare. Ceramide powders can resist blending or clog filters, stalling production runs and increasing labor costs. By using a fully-encapsulated, real-mimic liposomal form, bottling times shortened, and compacted storage reduced residues and waste. Our refining line designed its process with continuous mixing technology, tuned specifically for stable lipid-lipid vesicle production. This way, we minimized raw material losses and cut back on unplanned downtime—a practical difference seldom seen when working with older materials.

    One overlooked benefit came from reduced re-formulation cycles. Customers moving to our Five-fold Ceramide Biomimetic Liposome spent less time tweaking texture, viscosity, or phase compatibility. Through technical guidance and on-site support, they avoided the usual trial-and-error loop of making traditional ceramide blends work with new actives or thickeners. By starting with a structure that matches skin biology and handles industrial stresses, formulators got to market faster and more reliably.

    The Future and Our Commitment: Listening and Innovating

    Years of active listening to both formulators and users pushed us to create something that addressed real pain points in ceramide chemistry. Our drive hasn’t just been about pushing more ingredients into the supply chain—it’s about respecting what science and clinical reality demand from a product that claims to rebuild the skin barrier. Regular collaboration with academic and industry partners gives us data and insight to continue refining our processes and the composition of future batches.

    Ingredients trends come and go, but the fundamental challenge of supporting the skin barrier hasn’t changed. Our focus remains on advancing how skin-compatible technology is produced—delivering true-to-function ceramide blends, reducing unnecessary complexity, and sharing the hands-on technical expertise that comes from decades in the field. Our Five-fold Ceramide Biomimetic Liposome was born from this process, not just from lab theory, and it keeps evolving. With every batch, feedback loop, and field trial, we add to our knowledge—so our customers and their consumers notice the difference where it counts most.

    Collaborating With Industry: Practical Application and Support

    Our work doesn’t stop at manufacturing. We actively engage with formulation teams, sharing processing guides and troubleshooting techniques for real-world plants and lab settings. Staying in close contact with dermatology researchers, skincare developers, and QA staff helps us understand daily challenges and emerging needs. Many partners share their hurdles: temperature control in large batches, choosing compatible preservatives, blending with unstable botanicals, or avoiding phase separation after months of storage. By offering practical protocols and rapid batch testing, we help streamline their workflow—this commitment builds lasting technical partnerships, not just transactions.

    We believe open communication with the industry leads to smarter, more focused innovation in both ingredients and end products. Whether it’s running side-by-side comparisons with new anti-aging actives or advising on natural preservative systems, we bring our manufacturing insights into every collaboration. Product safety, load testing, and process optimization get equal attention at our facility, so what leaves our plant performs as promised.

    Conclusion: A Manufacturer's Perspective on What Matters Most

    Through years of working inside the factory—producing, troubleshooting, adapting—we learned what works and what falls short. The Five-fold Ceramide Biomimetic Liposome stands as a culmination of those lessons. By insisting on true biomimicry, multi-ceramide composition, and liposomal technology tested in real-world production, we raised the bar for functional skin barrier support. Each customer, batch, and clinical application pushes us to keep evolving—because in chemical manufacturing, success and reputation are built on evidence, not shortcuts.

    Top